Dr. Gurpreet Singh Padda, MD, MBA, MHP is the founder and Chief Medical Officer of the Padda Institute Center for Interventional Pain Management in St. Louis, Missouri. He has practiced interventional pain medicine in the St. Louis region for more than three decades. He holds diplomate status with five American specialty boards.
Five board certifications, and why the combination matters
Many doctors who advertise pain care are board certified in pain medicine. This mix of boards is rare. It is on purpose, not for show.
- American Board of Anesthesiology — Diplomate
- American Board of Interventional Pain Physicians (ABIPP) — Diplomate
- American Board of Pain Medicine — Diplomate
- American Board of Addiction Medicine — Diplomate
- American Board of Obesity Medicine — Diplomate
The anesthesiology and interventional pain boards cover the procedure work: placing a needle on an exact, named target, under imaging, safely. The addiction medicine board covers what really walks into a pain clinic. That is because many chronic pain patients arrive already on long-term opioids. Those drugs no longer help, and they cannot be stopped all at once. The obesity medicine board covers the metabolic ground the painful structure sits in. That is because insulin resistance, visceral fat (belly fat around the organs) and chronic inflammation change how the nervous system handles pain signals.
Most interventional practices refer the second and third of those out. Holding all three means one doctor can manage the whole picture, not just the part that fits the specialty.
Additional certifications
- Competency Certification in Regenerative Medicine in Interventional Pain Management, ABIPP (2024)
- Fellow of Interventional Pain Physicians (FIPP)
- Diplomate, Metabolic Health Practitioner
- Certified Physician Executive (CPE)
- MoCA Certified Rater (Montreal Cognitive Assessment)
Training
- Doctor of Medicine — University of Missouri–Kansas City School of Medicine
- Anesthesiology residency — Washington University / Barnes Hospital, St. Louis
- Master of Business Administration — Saint Louis University
Verify these credentials independently
Credentials are only worth as much as your power to check them. These are the primary sources, not testimonials:
- Individual NPI 1427035955 — verify in the CMS national provider registry
- Missouri medical license MD 100572 — issued by the Missouri Board of Registration for the Healing Arts
- American Board of Anesthesiology — theaba.org
- American Board of Interventional Pain Physicians — abipp.org
Hospital affiliation: Anderson Hospital, listed under Pain Management.
Independent physician directories carrying his profile include U.S. News, Healthgrades and Doximity.
Published research. His peer-reviewed record is registered under ORCID 0009-0001-0166-3186 and indexed at PubMed, OpenAlex and Semantic Scholar. His biographical record is Wikidata Q141049117.
Find Dr. Padda Online
Professional affiliations
- American Society of Interventional Pain Physicians (ASIPP)
- Society of Metabolic Health Practitioners (SMHP)
- Nutrition Network — advisor
- Low Carb USA — certified
Clinical focus
Dr. Padda treats chronic pain as a problem with structural, neurological and metabolic drivers, not a symptom to be medicated. In practice, the diagnosis comes first. He finds which exact structure is making the pain. He uses image-guided shots that double as diagnostic tests. Only then is any treatment aimed at it.
His areas of focus include interventional pain management, pain medicine, metabolic health, regenerative medicine, addiction medicine, obesity medicine and anesthesiology. A full account of how the practice applies that approach is on the pain management doctors page, and the procedures themselves are indexed in the interventional pain management guide.
Academic and professional leadership
Dr. Padda spent seven years on the faculty of Saint Louis University School of Medicine. Then he moved into full-time interventional pain practice.
- Assistant Professor, Anesthesiology (1992–1999) — Cardinal Glennon Children’s Hospital, Saint Louis University Health Sciences Center
- Assistant Professor, Pediatrics (1993–1999) — Cardinal Glennon Children’s Hospital
- Associate Director, Pediatric Anesthesiology (1995–1999) — Cardinal Glennon Children’s Hospital
- Director, Pediatric Acute Pain Management Service (1995–1999) — Cardinal Glennon Children’s Hospital
- Deputy Director, Institutional Review Board (1998–1999) — Saint Louis University School of Medicine
- Chairman, Department of Anesthesia, Perioperative Medicine and Pain Management — St. Joseph’s Hospital, Kirkwood (1999–2001) and St. Alexius Hospital, St. Louis (2000–2002)
- Faculty, Psychiatry Residency Program (2024–present) — KCU Freeman Health System, pain and addiction
Specialty society leadership:
- President, Missouri Society of Interventional Pain Physicians (2002–2010, and 2023–present)
- Board Member and Examiner, American Board of Interventional Pain Physicians (2007–2009)
- Board of Directors, American Society of Interventional Pain Physicians (2008–2010)
- Director at Large, Missouri Society of Interventional Pain Management (2010–2023)
- Chief Medical Officer, Center for Interventional Pain Management (2001–present)
- Medical Director, Center for Regenerative Medicine (2004–present)
He is licensed to practice medicine in Missouri and Illinois. He has held licenses in Arizona, New Mexico, Georgia and Florida. He is also a Department of Homeland Security–designated Civil Surgeon.
Selected peer-reviewed publications
Dr. Padda has published in anesthesiology, pain medicine, critical care and ophthalmology journals, and has served as a review editor for PharmacoEconomics. Every entry links to the paper itself.
- Padda G. The Future of the Independent Practice after COVID. Pain Physician. 2020;23(4S):S473–S474. PMID 32942810
- Rosen SM, Bromberg TA, Padda G, Barsa J, Dunbar E, Dwarakanath G, Navalgund Y, Jaffe T, Yearwood TL, Creamer M, Deer T. Intrathecal administration of Infumorph® vs compounded morphine for treatment of intractable pain using the Prometra® programmable pump. Pain Medicine. 2013;14(6):865–73. doi:10.1111/pme.12077
- Rauck R, Deer T, Rosen S, Padda G, Barsa J, Dunbar E, Dwarakanath G. Long-term follow-up of a novel implantable programmable infusion pump. Neuromodulation: Technology at the Neural Interface. 2013;16(2):163–7. doi:10.1111/j.1525-1403.2012.00515.x
- Rauck R, Deer T, Rosen S, Padda G, Barsa J, Dunbar E, Dwarakanath G. Accuracy and efficacy of intrathecal administration of morphine sulfate for treatment of intractable pain using the Prometra® Programmable Pump. Neuromodulation: Technology at the Neural Interface. 2010;13(2):102–8. doi:10.1111/j.1525-1403.2009.00257.x
- Rosen S, Deer T, Rauck R, Barsa J, Dwarakanath G, Dunbar E, Padda G. Multi-center evaluation of drug delivery accuracy with the Prometra intrathecal infusion pump. Pain Medicine. 2009;10:124.
- Padda GS, Kishioka C, Rubin BK. Propofol and methohexital have no significant effect on mucus secretion or clearance in the anesthetized dog. Critical Care Medicine. 2001;29(5):1045–8. doi:10.1097/00003246-200105000-00035
- Padda GS, Cruz OA, Silen ML, Krock JL. Skin conductance responses in paediatric Harlequin syndrome. Paediatric Anaesthesia. 1999;9(2):159–62. doi:10.1046/j.1460-9592.1999.9220266.x
- White JM, Siegfried E, Boulden M, Padda G. Possible hazards of cryogen use with pulsed dye laser. A case report and summary. Dermatologic Surgery. 1999;25(3):250–2; discussion 252–3. doi:10.1046/j.1524-4725.1999.08198.x
- Krock JL, Padda GS, Gabriel HF. Defeating proprietary technology. Anesthesiology. 1998;89(5):1292. doi:10.1097/00000542-199811000-00055
- Krock JL, Padda GS, Moore JD. Ohmeda 7900 Ventilator Flow Sensor failure. Anesthesia & Analgesia. 1998;87(1):231–2. doi:10.1097/00000539-199807000-00052
- Padda GS, Cruz OA, Krock JL. Comparison of postoperative emesis, recovery profile, and analgesia in pediatric strabismus repair. Rectal acetaminophen versus intravenous fentanyl-droperidol. Ophthalmology. 1997;104(3):419–24. doi:10.1016/s0161-6420(97)30298-x
- Azzam FJ, Padda GS, DeBoard JW, Krock JL, Kolterman SM. The cost of preoperative pregnancy testing [authors’ reply]. Anesthesia & Analgesia. 1996;83(2):439–40. doi:10.1097/00000539-199608000-00061
- Azzam FJ, Padda GS, DeBoard JW, Krock JL, Kolterman SM. Preoperative pregnancy testing in adolescents. Anesthesia & Analgesia. 1996;82(1):4–7. doi:10.1097/00000539-199601000-00002
- Padda GS, Bowen CH. Anesthetic implication of snake-bite envenomation. Anesthesia & Analgesia. 1995;81(3):649–51. doi:10.1097/00000539-199509000-00043
- Bamshad M, Rosa U, Padda G, Luce M. Acute upper airway obstruction in rheumatoid arthritis of the cricoarytenoid joints. Southern Medical Journal. 1989;82(4):507–11. doi:10.1097/00007611-198904000-00023
He was also a contributor to the Pain Medicine & Interventional Pain Management Board Review Self-Assessment (2011).
National presentations
Dr. Padda has twice delivered the keynote address at the American Society of Interventional Pain Physicians annual conference.
- ASIPP Keynote Speaker, July 2021, New Orleans — “Metabolic Inflammation and the Hedonic Treadmill: Leveraging Inflection Points”
- ASIPP Keynote Speaker, July 2020, Virtual Annual Conference — “Treating Metainflammation and Interventional Pain”
- ASIPP, 2025 — “Revenue Enhancement with Risk Reduction: Measuring Patient Outcomes”
- Society of Metabolic Health Practitioners / Low Carb USA, Boca Conference, January 2025 — “Reimagining Metabolic Health: Scaling Technology-Enabled Solutions”
- ASIPP, 2019 — “Metainflammation,” lecturer
- ASIPP Comprehensive Review Course in Controlled Substance Management, 2007 — lecturer
- ASIPP Comprehensive Pain Medicine Board Review Course, 2006 — lecturer on healthcare ethics, medicolegal issues in pain management and third-party payors
Earlier research was presented at the American Society of Anesthesiologists, the Society for Pediatric Anesthesia, the Society for Ambulatory Anesthesia, the American Academy of Ophthalmology and the American Thoracic Society.
Books
Four titles in The Brain series, published by Nectar Media Group.
- The Dopamine Brain: Wanting: Why You Chase What You Don’t Enjoy (September 2026) — why wanting and liking come apart, and what that does to motivation, appetite and relapse. ISBN 978-0-9832058-3-8.
- The Angry Gut: The First Brain: Older Than Thought, and Still in Charge (September 2026) — with Ami Michelle Grimes; the gut as the older brain, and what it governs before thought arrives. ISBN 978-0-9832058-2-1.
- The Pained Brain: Chronic Pain: Felt in the Body, Made in the Brain (September 2026) — with KrisJay Fucanan, MD; chronic pain as a centralized brain pathology fueled by metabolic inflammation. ISBN 978-0-9832058-1-4.
- The Starved Brain: Modern Nutrition: Overfed but Malnourished (September 2026) — reframing dementia as a metabolic disease of overnutrition, arguing that cognitive decline is driven by the malnutrition of excess. ISBN 978-0-9832058-0-7.
- Next Level Your Life (January 2023) — coauthor; an Amazon best seller in 41 categories.
- The Ideal.Fit Recipe Book: 175 Delicious Keto Recipes (May 2020) — with Ami Hendrix-Grimes.
Community and charitable work
Dr. Padda serves as Chief Medical Officer of Valor Villages, the St. Louis 501(c)(3) nonprofit that houses veterans and children in crisis. Clinical care for that work is delivered through Valor Medica, the partnership’s medical arm and a DBA of Sevadar Foundation Inc., a separate 501(c)(3). It focuses on the medical problems and life conditions that hit people moving out of homelessness — the people most housing programs are least equipped to treat.
- Valor Villages Opens Veterans Housing Facility in St. Louis (November 3, 2025) — medical care for formerly unhoused veterans, provided through Valor Medica.
- Valor Villages Receives $200,000 Boost Toward Launch of Sanctuary for Children in Crisis (January 16, 2026) — a seed funding commitment toward the $500,000 needed to open a residence for children in crisis.
- Valor Villages Launches Capital Campaign to Create 24-Bed Home for Unhoused Children (February 18, 2026) — expanding the effort into a 24-bed children’s residence.
Earlier and ongoing service includes medical missions to Honduras, Guatemala and Nicaragua with the Catholic Medical Mission Association. He has served on the March of Dimes Program Services and Public Affairs Committees as a nonprofit board director. He has held board roles with Exoneration Nation and Arise Veterans. From 2023 to 2026 he also sat on the boards of directors of two real estate development funds, Grocapitus Investments and UGRO. He serves as Executive Director of the Deva Singh Foundation.
He has also spoken outside medicine on how health, prison and financial stability connect. One example is a 2019 talk for Exonerated Nation with Loyola Law School and Kaiser Permanente Northern California Community Benefit Programs.
As Seen In
Our releases ran on AP News, The National Law Review, FOX 2 St. Louis and 570+ other news sites across the United States and Canada.
- 12press releases
- 4,600+news placements
- 580+news outlets
- 110+TV station sites
- AP News
- The National Law Review
- FOX 2 St. Louis
- WGN-TV Chicago
- PIX11 New York
- KRON 4 San Francisco
- Detroit Free Press
- The Detroit News
- The Indianapolis Star
- The Tennessean
- Milwaukee Journal Sentinel
- The Arizona Republic
- The Des Moines Register
- The Cincinnati Enquirer
Distributed by EIN Presswire for Nectar Media Group.
Press and media
Announcements from the practice are collected under News & Press. Releases are distributed through Nectar Media Group’s EIN Presswire newsroom.
- Dr. Gurpreet Singh Padda, MD: Trial Suggests PRP May Delay Knee Replacement for Patients Already on the Surgical List (October 12, 2026) — EIN Presswire, World Arthritis Day: a randomized trial in patients already on the knee replacement list, read as the authors framed it, PRP as a bridge before surgery and not cartilage regrowth.
- Dr. Gurpreet Singh Padda, MD Puts the New Low-Carb Guideline to Work in Pain Care: Medicines Change Before Pain Does (October 7, 2026) — the Society of Metabolic Health Practitioners’ 2026 low-carb guideline applied to pain care: a pain patient’s medicines change in the first week, before the pain does. Original release on EIN Presswire.
- Dr. Gurpreet Singh Padda, MD Publishes The Dopamine Brain: Dopamine Is Not the Pleasure Chemical We Thought (October 5, 2026) — the fourth book in The Brain: dopamine drives wanting, not liking, and treatment built on the pleasure model aims at the wrong target. Carried by AP News, The National Law Review, KTVI FOX 2 St. Louis, KOLR 10 Springfield and KSN/KODE 12 Joplin.
- Dr. Gurpreet Singh Padda, MD Publishes ‘The Angry Gut, Your First Brain’ (September 28, 2026) — the third book in The Brain, coauthored with Ami Michelle Grimes: the gut’s nervous system came first, and an inflamed first brain cannot produce a calm second one. Carried by AP News , The National Law Review, Columbia Daily Tribune, Springfield News-Leader, KSN/KODE Joplin, The Detroit News, WGN-TV Chicago and PIX11 New York, among more than 850 news sites.
- Dr. Gurpreet Singh Padda, MD Publishes The Pained Brain, Arguing Chronic Pain Is a Metabolic Disease the Scan Cannot See (September 21, 2026) — the second book in The Brain, coauthored with Dr. KrisJay Fucanan, MD: chronic pain as a metabolic disease the scan cannot see. Carried by AP News and The National Law Review.
- Dr. Gurpreet Singh Padda, MD Discusses Alzheimer’s Research, Not Just Plaque (September 21, 2026) — on World Alzheimer’s Day, the case that cognitive decline is a fuel and inflammation failure that starts decades before the plaque. Carried by AP News and The National Law Review.
- International Overdose Awareness Day: Padda Institute Publishes Its Own Opioid Numbers (August 31, 2026) — practice-reported opioid outcomes, and the argument that tapering a dose and treating the pain generator are not the same intervention.
- New Book The Starved Brain by Dr. Gurpreet Padda Reframes Dementia as a Metabolic Disease of Overnutrition (July 23, 2026) — on cognitive decline driven by the malnutrition of excess rather than of scarcity.
- FDA Advisory Committee Convenes on Peptides: Understanding What Reclassification Means (July 20, 2026) — a patient education initiative on peptide sourcing and marketing claims.
- Patients Already on the Knee Replacement Waiting List Find Platelet-Rich Plasma Outperformed Cortisone and NSAIDs (July 19, 2026) — on a randomized trial measuring cartilage breakdown and inflammatory biomarkers.
- Padda Institute Relocates to Expanded State-of-the-Art Facility (March 1, 2026) — the move to the Woodson location, expanding access to hospital-free interventional pain, injury rehabilitation and metabolic health services. Also carried by The National Law Review.
Interviews and speaking
Dr. Padda talks about how chronic pain, inflammation and metabolic health connect in long-form conversations, collected under Expert Interviews.
- Why Medications, Procedures, and Surgery May Not Fix Chronic Pain — in conversation with Dr. Tony Hampton, on why pain can persist long after an injury has healed.
- How Inflammation and Diet Drive Chronic Pain and Hormone Problems — on the Low Carb & Fasting podcast, on why stubborn back, neck and migraine pain is often not purely structural.
Writing on pain medicine
Dr. Padda’s clinical commentary on this site is organized by theme: Hidden Drivers of Chronic Pain, Metabolic & Lifestyle Medicine, Interventional Pain Treatments and Opioid Stewardship.
Where does Dr. Padda see patients?
Dr. Padda sees patients at both Padda Institute offices:
- St. Louis (primary): 4477 Woodson Rd, Suite 100, St. Louis, MO 63134
- Natural Bridge Road: 12174 Natural Bridge Rd, St. Louis, MO 63044
Monday through Friday, 8:00 AM to 5:00 PM. Full directions and maps are on the locations page.
How do I make an appointment with Dr. Padda?
To see Dr. Padda, request an appointment or call us. Same-day visits are held for urgent pain problems. You can also text us.
Board certifications and professional affiliations
Dr. Gurpreet Singh Padda, MD, MBA, MHP holds five board certifications and maintains the professional affiliations below.
